Skip to main content

Rice University, MD Anderson Land $20M to Create Pre-commercialization Center

NEW YORK (GenomeWeb News) – The Cancer Research and Prevention Institute of Texas has awarded $20 million to Rice University and The University of Texas MD Anderson Cancer Center to create a pre-commercialization center to help commercialize new diagnostics products and treatments for cancer.

The center will be located at Rice University's BioScience Research Collaborative (BRC) and will connect researchers from Rice and partner Texas Medical Center institutions and entrepreneurs with funding and management experts, Rice said.

The center will be operated by the Houston-Area Translation Research Consortium (HATRC) in collaboration with the new Institute for Applied Cancer Science (IACS) at The University of Texas MD Anderson Cancer Center.

It is unclear what new technologies will be evaluated by the new center, and a university administrator said through a spokesman only that HATRC "is charged with reviewing all of these technology classes that are generated in the Houston area."

Cindy Farach-Carson, Rice's vice provost for translational bioscience and scientific director of the BRC, said in a statement IACS "will bring together the drug discovery, personalized medicine, clinical trials, and patient access and data from the largest cancer center in the world to the mission of accelerating translation and driving development of new cancer medicines."

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.